Determining whether an ER patient has a life threatening disease, PREtest Consult
The risk score generated by this test aids physicians in their decision to pursue further testing and hospitalization.
If the physician discharges the patient without further workup, the physician has mitigated malpractice risk by documenting his/her quantitative basis for decision making. At the same time, this quantitative basis also helps in reducing unnecessary testing, which is a known contributor to the overcrowding epidemic that affects hospitals across the country.
Presently, PREtest Consult modules exist for the conditions of acute coronary syndrome and pulmonary embolism. The two conditions, which account for ten million visits to United States emergency department annually, prove challenging to physicians. Presently, overtreatment of these diseases results in unnecessary annual expenditures of over three billion dollars; however, undertreatment of the disease results in a quarter of all lawsuits filed against Emergency Medicine practitioners.
BreathQuant Medical Systems, Inc. is located in Charlotte, North Carolina. The Company develops bedside, non-invasive diagnostic products intended to:
_-- inexpensively screen for life threatening diseases such as Acute Coronary Syndrome and Pulmonary Embolism.
_-- reduce medical errors and unnecessary test ordering.
_-- provide rapid and yet inexpensive triage and improved better outcomes while improving throughput in resource constrained Emergency Departments.
_-- provide physicians with statistical documentation around their admit/discharge decisions.
For more information, please visit the website at http://www.pretestconsult.com or contact Baxter Webb at bwebb@pretestconsult.com.
ER stabili dacã un pacient are o boalã care ameninþã viaþa, PREtest Consult - Determining whether an ER patient has a life threatening disease, PREtest Consult - articole medicale engleza - startsanatate